Cell Therapy Development for Incurable Diseases
Sector: Healthcare • Location: India
Source: Business Standard
Eyestem Research is developing first-in-class cell therapies for two globally incurable diseases: dry age-related macular degeneration (geographic atrophy) and idiopathic pulmonary fibrosis. The project aims to advance healthcare innovation through indigenous biotechnology solutions.
- Status
- Prospective
- Sector
- Healthcare
- Location
- India
- Updated
- 22 Jul 2026
- Source
- Business Standard
ConstructChat
Ask ConstructChat about Cell Therapy Development for Incurable Diseases
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Eyestem Research is developing first-in-class cell therapies for two globally incurable diseases: dry age-related macular degeneration (geographic atrophy) and idiopathic pulmonary fibrosis. The project aims to advance healthcare innovation through indigenous biotechnology solutions. |
Original sector | Healthcare |
Budget |
Location
Country | India |
Source
Source | Business Standard |
URL |
More Details
Record type | Project |
Article published date | 2026-07-11 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project